Compounds > 4-nitroquinoline-1-oxide
Page last updated: 2024-08-17

4-nitroquinoline-1-oxide and propranolol

4-nitroquinoline-1-oxide has been researched along with propranolol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bernabé, DG; Biasoli, ÉR; Cecilio, HP; Furuse, C; Kayahara, GM; Miyahara, GI; Oliveira, SHP; Pereira, KM; Valente, VB1
Carrard, VC; Castilho, RM; Gaio, EJ; Nör, F; Rösing, CK; Spuldaro, TR; Wagner, VP1

Other Studies

2 other study(ies) available for 4-nitroquinoline-1-oxide and propranolol

ArticleYear
Beta-adrenergic blocker inhibits oral carcinogenesis and reduces tumor invasion.
    Cancer chemotherapy and pharmacology, 2020, Volume: 86, Issue:5

    Topics: 4-Nitroquinoline-1-oxide; Adrenergic beta-Antagonists; Animals; Carcinogenesis; Carcinogens; Cytokines; Disease Progression; Humans; Male; Mouth Mucosa; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasms, Experimental; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment

2020
Can propranolol act as a chemopreventive agent during oral carcinogenesis? An experimental animal study.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2021, 07-01, Volume: 30, Issue:4

    Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinogenesis; Carcinogens; Carcinoma, Squamous Cell; Disease Models, Animal; Humans; Mouth Neoplasms; Propranolol; Rats; Rats, Wistar; Tongue Neoplasms

2021